Reply to Daitch et al. Comment on “Huang et al. Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection: A Meta-Analysis. J. Clin. Med. 2022, 11, 3239”

Detalles Bibliográficos
Autores principales: Huang, Chienhsiu, Chen, Ihung, Tang, Tiju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Reply
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788436/
https://www.ncbi.nlm.nih.gov/pubmed/36556126
http://dx.doi.org/10.3390/jcm11247508
_version_ 1784858753958412288
author Huang, Chienhsiu
Chen, Ihung
Tang, Tiju
author_facet Huang, Chienhsiu
Chen, Ihung
Tang, Tiju
author_sort Huang, Chienhsiu
collection PubMed
description
format Online
Article
Text
id pubmed-9788436
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97884362022-12-24 Reply to Daitch et al. Comment on “Huang et al. Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection: A Meta-Analysis. J. Clin. Med. 2022, 11, 3239” Huang, Chienhsiu Chen, Ihung Tang, Tiju J Clin Med Reply MDPI 2022-12-19 /pmc/articles/PMC9788436/ /pubmed/36556126 http://dx.doi.org/10.3390/jcm11247508 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Reply
Huang, Chienhsiu
Chen, Ihung
Tang, Tiju
Reply to Daitch et al. Comment on “Huang et al. Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection: A Meta-Analysis. J. Clin. Med. 2022, 11, 3239”
title Reply to Daitch et al. Comment on “Huang et al. Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection: A Meta-Analysis. J. Clin. Med. 2022, 11, 3239”
title_full Reply to Daitch et al. Comment on “Huang et al. Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection: A Meta-Analysis. J. Clin. Med. 2022, 11, 3239”
title_fullStr Reply to Daitch et al. Comment on “Huang et al. Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection: A Meta-Analysis. J. Clin. Med. 2022, 11, 3239”
title_full_unstemmed Reply to Daitch et al. Comment on “Huang et al. Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection: A Meta-Analysis. J. Clin. Med. 2022, 11, 3239”
title_short Reply to Daitch et al. Comment on “Huang et al. Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection: A Meta-Analysis. J. Clin. Med. 2022, 11, 3239”
title_sort reply to daitch et al. comment on “huang et al. colistin monotherapy versus colistin plus meropenem combination therapy for the treatment of multidrug-resistant acinetobacter baumannii infection: a meta-analysis. j. clin. med. 2022, 11, 3239”
topic Reply
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788436/
https://www.ncbi.nlm.nih.gov/pubmed/36556126
http://dx.doi.org/10.3390/jcm11247508
work_keys_str_mv AT huangchienhsiu replytodaitchetalcommentonhuangetalcolistinmonotherapyversuscolistinplusmeropenemcombinationtherapyforthetreatmentofmultidrugresistantacinetobacterbaumanniiinfectionametaanalysisjclinmed2022113239
AT chenihung replytodaitchetalcommentonhuangetalcolistinmonotherapyversuscolistinplusmeropenemcombinationtherapyforthetreatmentofmultidrugresistantacinetobacterbaumanniiinfectionametaanalysisjclinmed2022113239
AT tangtiju replytodaitchetalcommentonhuangetalcolistinmonotherapyversuscolistinplusmeropenemcombinationtherapyforthetreatmentofmultidrugresistantacinetobacterbaumanniiinfectionametaanalysisjclinmed2022113239

Ejemplares similares